Foghorn Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Foghorn Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Foghorn Therapeutics Inc
Rating: 0.97783325
Author: Trendlyne DVM scores

about

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin r...

4.04 -0.13 (-3.12%)

41.87% Fall from 52W High

110.4K

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Foghorn Therapeutics Inc is on 20 May 2026 for the purpose of 2026 Stifel Virtual Targeted Oncology Forum See details

Not Eligible

Expensive Valuation

7.8 / 100

Technically Bearish

31.3 / 100

1Yr Price target upside is 183%

9 analysts

Foghorn Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Foghorn Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin r...

41.87% Fall from 52W High

SWOT Analysis

Foghorn Therapeutics Inc Live Price Chart